The healthcare and life sciences industry has proven its resilience through the COVID-19 pandemic. Healthcare M&A volume hit a record high in Q1 2021, with 605 deals announced, indicating strong investor confidence. Sectors that experienced surges in demand due to COVID-19, including outsourced pharma services, behavioral health, and tech-enabled services like telehealth and payments technology, are performing particularly well. Another indicator of resilience in the sector, physician practice management activity has picked up considerably after a slowdown in the first half of 2020.
Read more in our Q1 Healthcare & Life Sciences Industry Update, which explores key trends and data across the industry’s M&A market. Please contact us directly if you would like to discuss our perspective on today’s market, M&A opportunities, or our experience in the space.
Topics Covered
-
M&A Market Update
-
Debt Market, Public Market, and Equity Market Overviews
- Recent M&A Transactions
- Articles We’re Reading
- Public Comparables